Other OTC - Delayed Quote USD

Citrine Global Corp. (CTGL)

0.0125 0.0000 (0.00%)
At close: April 15 at 3:11 PM EDT
Key Events
Loading Chart for CTGL
DELL
  • Previous Close 0.0125
  • Open 0.0125
  • Bid --
  • Ask --
  • Day's Range 0.0125 - 0.0125
  • 52 Week Range 0.0050 - 0.0420
  • Volume 2
  • Avg. Volume 646
  • Market Cap (intraday) 12.071M
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Citrine Global Corp. operates as a plant-based wellness and pharma solutions company in Israel. The company focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. It offers SmokLy sprays for cannabis users and tobacco smokers; and DryLess sprays for adult population with constant dry mouth, and other cancer treatment patients with constant dry mouth as part of their cancer treatment regimen. The company was formerly known as TechCare Corp. and changed its name to Citrine Global Corp. in August 2020. Citrine Global Corp. was incorporated in 2010 and is headquartered in Caesarea, Israel.

www.citrine-global.com

18

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CTGL

Performance Overview: CTGL

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CTGL
37.50%
S&P 500
6.92%

1-Year Return

CTGL
68.75%
S&P 500
25.26%

3-Year Return

CTGL
80.47%
S&P 500
22.00%

5-Year Return

CTGL
94.75%
S&P 500
74.29%

Compare To: CTGL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CTGL

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    12.07M

  • Enterprise Value

    14.26M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -6.99

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -103.25%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -2.38M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    58k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    294.62k

Company Insights: CTGL

People Also Watch